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Abstract
Interval censored survival data, where the exact event time is only known to lie in
an observed time interval, is commonly encountered in practice. Such data analysis
may be conducted under the setting where a fraction of patients can be considered
as fully recovered and will not experience the event of interest in the future; while
the other patients who did not recover totally will have the outcome of interest. We
proposed a semiparametric estimation method for the proportional hazard mixture
cure model, which is easy to implement and computationally efficient. A multiple
imputation approach based on the asymptotic normal data augmentation (ANDA)
is used to obtain parameter and variance estimates for both the cure probability and
survival probability for uncured patients. A simulation study is performed to evaluate
the proposed method and the results are compared with a fully parametric approach.
The proposed method is applied to 2000-2010 Greater Georgia breast cancer dataset
from the Surveillance, Epidemiology, and End Results (SEER) Program.
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Survival analysis is a subject studying statistical methods for analyzing and mod-
eling lifetime data or failure time data. Two main purposes in survival analysis are:
estimating the survival probabilities and building regression models between survival
time and predictors of interest. One of difficulties lies in analyzing survival data is
that it is very likely to be right or interval censored.
1.1 Censoring Data
Time-to-event data present themselves in different ways which create special prob-
lems in analyzing such data. One particular feature, often present in time-to-event
data, is known as censoring, which, broadly speaking, occurs when some lifetimes are
known to have occurred only within certain intervals. There are various categories of
censoring, such as right censoring, left censoring, and interval censoring.
Right censored data
In right censoring, the event is observed only if it occurs prior to some prespecified
time. For a specific individual under study, we assume that there is a lifetime X and a
censoring time, C. TheX ′s are assumed to be independent and identically distributed
with probability density function f(x) and survival function S(x). The exact lifetime
X of an individual will be known if, and only if, X is less than or equal to C. If X is
1
greater than C, the individual is a survivor, and his or her event time is censored at C.
The data can be conveniently represented by pairs of random variables (T, δ), where δ
indicates whether the lifetime X corresponds to an event (δ = 1) or censored (δ = 0),
and T is equal to X, if the lifetime is observed, and C if censored, i.e., T = min(X,C).
For right censored data, the commonly used nonparametric technique for estimat-










where t(i) is the ith ordered event times with t(1) ≤ t(2) ≤ · · · ≤ t(k), if we have to-
tal of k events. di and ni are number of events and number of cases at risk at time t(i).
Interval censored data
Interval censored survival data is also commonly encountered in practice. For
example, in medical research, animal carcinogenicity and epidemiological study ([4],
[6]) when patients in a clinical trial or longitudinal study have periodic follow-ups or
in industrial experiments where there is periodic inspection for proper functioning of
equipment items. In most studies, we know the event happened or will happen in a
certain time interval based on a sequence of examination times instead of exact event
time. That is, each patient have an observed time interval (L,R] which includes the
true event time of interest. When L = 0 it is left censored, and if R = ∞ it is right
censored.
There are many discussions on the estimation methods for survival probabilities
under such data. Turnbull [24] developed a self-consistency algorithm for comput-
ing nonparametric maximum likelihood estimator (NPMLE); and Groeneboom and
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Wellner [5] proposed an Iterative Convex Minorant (ICM) algorithm for NPMLE,
which is considerably faster than Turnbull’s method when the sample size is large.
1.2 Proportional Hazards Model
In the proportional hazrds (PH) model [3], the hazard function h(.) is assumed
to be the product of a baseline hazard function h0(.) and an exponential linear com-
bination of covariates x, that is
h(t|x) = h0(t)× eβ
′x
Under the PH model, the hazard ratio of two subjects is invariant over time. For
example, the hazard ratio of two patients with covariates x1 and x2 is




which is a constant over time. An appealing property of the PH model is that, even
though the baseline hazard function h0(.) is unspecified, it is still possible to esti-







where R(t(j)) is the risk set at time t(j) which includes all the subjects that are alive
at time t(j). Estimates based on the partial likelihood function are efficient and con-
sistent. It also satisfies the asymptotic normality.
The interpretation of the PH model will be mainly focused on hazard ratios. The










where di is the number of events at time ti.
Because we can obtain the corresponding survival curves S(t|x) without specify-
ing the baseline hazard function, the PH model is most popular in survival analysis.
The existing package, such as “phreg" in SAS and “coxph" in R, make the PH model
very easy to use in practice.
Therefore, we still consider the PH model due to its good properties and straight-
forward interpretation based on hazard ratios in the interval censored data. However,
the partial likelihood does not work under the PH model when the data is interval cen-
sored. There are several ways to estimate coefficients and the baseline hazard function
for PH model with interval censored data. Basically, it is a maximization problem
subject to monotonicity constraints on the part of cumulative hazard function. For
example, a two-step algorithm, or sometimes called generalized Gauss-Seidel algorith-
m [7], is usually recommended to get the maximum likelihood estimators. However,
the algorithm could be very slow to compute the profile likelihood curve when sample
size is large.
Pan [13] extended the ICM algorithm to the PH model with interval censored sur-
vival data. However, the variance for the estimated coefficients needs to be obtained
separately through resampling. Later, Pan [12] proposed a multiple imputation ap-
proach for the PH model under the interval censored data based on the Poor Man’s
data augmentation (PMDA) and Asymptotic Normal data augmentation (ANDA)
[25]. These two approaches are approximately equivalent except that PMDA will un-
derestimate the variance when the data have heavy right censoring. The advantage
of the multiple imputation is that one can obtain the estimates and their variances
simultaneously. The estimation in the multiple imputation used the partial likelihood
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estimates for the PH model, the implementation is straightforward and efficient.
1.3 Imputation Approach
Interval-censored data are usually regarded as incomplete data, and imputation
or multiple imputation is a general approach for handling missing data or incomplete
data problems. The general idea of imputation for observed dataO = {Lj, Rj,xj; j =
1, 2, · · · , n} is to generate one or multiple sets of right censored failure time for Tj’s
using the observed data. Then use these new data DI = {Tj, δj = 1(Rj<∞),xj; j =
1, 2, · · · , n} to do estimation and inference about unknown parameters.
For single point imputation approaches, we can use left end point (Tj = Lj) or
middle point (Tj = (Lj + Rj)/2 for δRj = 0 and Tj = Lj for δRj = 1) for event
times. For multiple imputation, we need to use some data augmentation algorithms
to impute values for Tj several times and get estimates iteratively.
To be specific, say our interest is to make inference about unknown parame-
ter θ and survival probabilities S(t) based on the observed interval censored data
O = {Lj, Rj,xj; j = 1, 2, · · · , n}. The general steps for multiple imputation are as
follows:
Step0: Give initial values θ̂(0) and Ŝ(0)(t)
Step1: At ith iteration and kth imputation: let T (i)(k),j = Lj and δ
(i)
(k),j = 0 if Rj =∞,
otherwise, sample T (i)(k),j from Ŝ(i−1)(t) conditional on T
(i)
(k),jε(Lj, Rj] and let δ
(i)
(k),j = 1.




(k),j; j = 1, · · · , n}, k =
1, · · · ,m.




(k)(t) for each D
(i)
I(k), k = 1, · · · ,m.
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Step4: Repeat Steps 1-3 until convergence.
The initial values in Step 0 can be obtained through some single point imputation
approach, for example, mid-point imputation. The advantage of multiple imputation
is that the variance estimate includes both the within imputation variance and the
between imputation variance. The weight 1 and 1+1/m, where the additional weight
for between imputation variance is used to account for the finite number of imputa-
tions.
1.4 Mixture Cure Model
As we all know that, regular survival models assume that all the subjects will
have the event of interest eventually, but nowadays we have many diseases such as
prostate cancer and breast cancer that are curable. Where a fraction of patients can
be considered as fully recovered after some treatment and will not experience the
event of interest in the future; while the other patients who did not recover totally
will have a survival probability. In this case, the regular survival models are not
appropriate and we need to use mixture cure models.
The most popular approach in analyzing survival data with potentially cured
patients is the mixture cure model proposed by Boag [1], which has been commonly
used in the last decade. Let T be a nonnegative random variable denoting the failure
time of a patient, and S(t) be the survival functions of T , The mixture cure model is
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given by
S(t) = 1− π + πSu(t),
where π is the proportion of uncured patients and Su(t) denotes the survival proba-
bility of uncured patients.
There are two components in the mixture cure model: the cure rate component,
sometimes called the incidence part and a survival model for the uncured patients,
sometimes called the latency part. After 1950, there are many discussions on this
model. The patients’ characteristic and other possible risk factor have been incorpo-
rated into the incidence and latency part.
For right censored data, an EM algorithm was proposed by Peng [14] for fitting
the mixture cure model, and an R package “smcure" was contributed by Cai [2] to
realize this method.
There is sparse research that focuses on the mixture cure model with interval cen-
sored data. For current status data, Ma [11] used the penalized maximum likelihood
method, where the baseline hazard is updated through the pool-adjacent violator al-
gorithm separately, and the weighted bootstrap was adopted for variance estimation.
For interval censored data, Kim [8] proposed the EM algorithm to estimate the mix-
ture cure model by assuming a piecewise exponential distribution for the baseline
hazard with multiple imputation to estimate the variance. Later, a multiple impu-
tation method based on ANDA was discussed in Lam [10] to deal with a frailty cox
PH model under right censoring and interval censoring case. The frailty term was
assumed to follow a noncentral chi-square distribution with zero degree of freedom
and was updated in the algorithm using the posterior gamma distribution.
7
1.5 Outline of Thesis
The main aim of this thesis is to develop a semiparametric estimation method for
the mixture cure model for interval censored data, which is easy to implement and
efficient in computation. We adopt the multiple imputation approach based on the
PMDA and ANDA in the proportional hazard mixture cure (PHMC) model for the
interval censored data. The attractive property of the proposed method is that it can
be easily implemented using existing functions in statistical software, such as “glm"
and “coxph" in R [16].
In Chapter 2, we introduce the multiple imputation algorithms. We outline the
notation, model description of the proportional hazards mixture cure model in 2.1.
Then the algorithm based on PMDA and ANDA will be discussed in Section 2.3
separately. We conduct extensive simulation studies in Chapter 3. We evaluate the
performance of the multiple imputation approach based on the PMDA, ANDA and
the parametric methods in Section 3.1. We also carry out a sensitivity analysis regard-
ing to the misspecification of cure rate component in Section 3.2. And a sensitivity
analysis to compare the rounding down survival time of right censored data and in-
terval censored data in Section 3.3. In Chapter 4, we apply the proposed methods to
the 2000-2010 Greater Georgia breast cancer SEER dataset. Both of the crude model
and adjusted model are fitted and discussed. Finally, we finish with a discussion and
conclusions in Chapter 5.
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Chapter 2
Multiple imputation Algorithm for PHMC
model with Interval censored data
2.1 Proportional Hazards Mixture Cure Model
Let T be a nonnegative random variable denoting the failure time of a patient,
and S(t|x, z) be the survival functions of T , where x and z are observed values of
two covariate vectors on which the distribution of T may depend. The mixture cure
model is given by
S(t|x, z) = 1− π(z) + π(z)Su(t|x),




1 + eγ′z ,
and Su(t|x) denotes the survival probability of uncured patients depending on x.
Note, as mentioned in Price [15], other link functions can also be specified for π(z),
such as the probit link (π(z) = Φ(γ ′z)) and complementary log-log link (π(z) =
1 − e−eγ





where Su0(·) is the survival function of baseline distribution. We refer to this as the
proportional hazard mixture cure (PHMC) model.
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Let O = (Lj, Rj, δLj , δRj , δIj ,xj, zj, j = 1, 2, . . . , n) denote the observed data,
where (Lj, Rj] is the observed time interval including the exact event time Tj for
the jth subject, and δLj , δRj , δIj are the censoring indicators. δLj = 1 when it is left
censored (Lj = 0); δRj = 1 when it is right censored (Rj = ∞); and δIj = 1 when it
is interval censored (0 < Lj < Rj <∞) with the convention that δLj + δIj + δRj = 1
for all j.
2.2 Likelihood Function
Assuming the censoring is independent and non-informative, the observed likeli-
hood function of interval censored data is
n∏
j=1
[1− S(Rj|xj, zj)]δLj [S(Lj|xj, zj)− S(Rj|xj, zj)]δIjS(Lj|xj, zj)δRj







× [1− π(zj) + π(zj)Su0(Lj)e
β′xj ]δRj (2.1)
Once π(zj) and Su0(·) are fully specified, the unknown parameters can be ob-
tained directly from maximum likelihood estimation. The disadvantage of the fully
parametric approach is that it is hard to verify the appropriate parametric form or
there may not exist a specific parametric form for a particular data. When this is
the case, semiparametric estimation is preferred. However, it is a challenge task to
achieve the semiparametric estimation method under the mixture cure model with
interval censored data.
For the purpose of computation, it is convenient to define a latent variable uj, j =
1, · · · , n, which is the uncure indicator where uj = 1 if the jth subject is uncured and
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0 if cured. Here, we have uj = 1 if δLj = 1 or δIj = 1. There is the probability of
being cured for the right censored observations, and its contribution to the likelihood
function is [1 − π(zj)] when uj = 0 and [π(zj)Su0(Lj)e
β′xj ] when uj = 1. Thus, the







× [1− π(zj)](1−uj)δRj [π(zj)Su0(Lj)e
β′xj ]ujδRj (2.2)
Using the fact that (1−uj)δRj = 1−uj, we can simplify the conditional likelihood
function as














If u can be observed, the likelihood function can be estimated by maximizing L1(γ)
and L2(β, Su0) separately regarding to β, γ and Su0.
Using a similar idea as Lam [9], we impute the uncure rate indicator uj through the
binomial distribution with probability being conditioned on the censoring indicators.
The conditional expectation of uj given (β,γ, Su0,O) is
wj = E(uj|β,γ, Su0,O)
= 1− δRj + δRj
π(zj)(Su0)e
β′xj
1− π(zj) + π(zj)(Su0)e
β′xj
(2.3)
Where wj is 1 when time is left or interval censored, which indicates the patients
are uncured, and a probability of being cured for right censored observations. Then
we sample u = (u1, u2, · · · , un) from a Bernoulli distribution with the probability
11
w = (w1, w2, · · · , wn). Conditional on u, we can estimate γ by maximize L1(γ)
through generalized linear models using “glm" in R, and β by maximizing L2(β, Su0)
through semiparametric approach using “intcox" package in R. However, there exist
some issues related with “intcox" in this approach: sometimes the algorithm cannot
converge; there is no variance estimation directly from “intcox"; and the computa-
tional speed is slow. Therefore, instead of estimating β directly from the interval
censored data, we adopt the method in Pan [12], where β is estimated through the
multiple imputation with right censored data through “coxph" function in R.
2.3 Multiple Imputation Algorithms
Follow Wei and Tanner [25] and Pan [12], we develop multiple imputation al-
gorithms based on the Poor man’s data augmentation (PMDA) and the asymptotic
normal data augmentation (ANDA) under the PHMC model for interval censored
data.
We use the superscript i and subscript k to denote the ith iteration and the kth








(k) are the vectors
of imputed cure indicators and event times.
Algorithm based on PMDA
The details of our algorithm based on PMDA are as follows:
Step 1: Initial values: let u(0) = 1− δR, and T (0) be the midpoints of time intervals
(L,R) (see Sun [19]) for uncured patients only (u(0) = 1). We fit a logistic regression
with u(0) and z to get γ̂(0). We also fit a Cox PH model for {T (0), 1− δR,x} and get
β̂(0) and estimate for baseline survival function Ŝ(0)u0 .
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Step 2: Multiple imputation: Assume that the estimates from the ith iteration are
denoted as (γ̂(i), β̂(i), Ŝ(i)u0 ). For the (i+ 1)th iteration, we impute the cure indicator
u(i+1) and the survival time T (i+1) for the interval censored observation m times.
Specifically, in the kth (k = 1, · · · ,m) imputation,
















(k) ), where Ber(.) is the Bernoulli
distribution.
(s2b) Sample T (i+1)(k),j from the time intervals (Lj, Rj], (j = 1, · · · , n) in the following
way: if subject j is right censored, we keep it and let T (i+1)(k),j = Lj and δ
(i+1)
(k),j = 0;









(k) xj , conditional on (Lj, Rj]
and let δ(i+1)(k),j = 1.
(s3) Use the imputed cure rate indicator in (s2a) as outcome to update γ̂(i+1)(k) using
the logistic regression.
(s4) Fit the PH model for uncured patients only (u(i+1)(k) = 1 from (s2a)) with the
imputed data set {T (i+1)(k) , δ
(i+1)
(k) ,x} and get estimates β̂
(i+1)
(k) , and Ŝ
(i+1)
u0(k) .
Step 3: Calculate updated estimates: at the end of each iteration, we can obtain the



























Step 4: Repeat Step2− Step3 until convergence. For the convergence criterion, we
use max{(β̂(i) − β̂(i−1))2, (γ̂(i) − γ̂(i−1))2} < .001 or i > 100.
After convergence, the variance of the coefficients can be obtained using estimates







































Algorithm based on ANDA
The details of our algorithm based on ANDA are as follows:
Step 1: Initial values: let u(0) = 1− δR, and T (0) be the midpoints of time intervals
(L,R) (see Sun [19]) for uncured patients only (u(0) = 1). We fit a logistic regression
with u(0) and z to get γ̂(0) and the covariance matrix estimate Σ̂(0)γ . We also fit a Cox
PH model for {T (0), 1− δR,x} and get β̂(0), covariance matrix Σ̂(0)β and estimates for
baseline survival Ŝ(0)u0 .
Step 2: Multiple imputation: assume that the estimates from the ith iteration are




u0 ). For the (i+ 1)th iteration, we impute the cure
indicator u(i+1) and the survival time T (i) for the interval censored observation m
times. Specifically, in the kth (k = 1, · · · ,m) imputation,
(s1) Sample β and γ from the normal distributions: β ∼ N(β̂(i), Σ̂(i)β ) and γ ∼






















(k) ), where Ber(.) is the Bernoulli
distribution.
(s3b) Sample T (i+1)(k),j from the time intervals (Lj, Rj], (j = 1, · · · , n) in the following
way: if subject j is right censored, we keep it and let T (i+1)(k),j = Lj and δ
(i+1)
(k),j = 0;









(k) xj , conditional on (Lj, Rj]
and let δ(i+1)(k),j = 1.
(s4) Use the imputed cure rate indicator in (s3a) as outcome to update γ̂(i+1)(k) and
Σ̂(i+1)γ(k) using the logistic regression.
(s5) Fit the PH model for uncured patients only (u(i+1)(k) = 1 from (s3a)) with the
imputed data set {T (i+1)(k) , δ
(i+1)







Step 3: Calculate updated estimates: at the end of each iteration, we can obtain the



























































Step 4: Repeat Step2 − Step3 until convergence. For the convergence criterion in
Step 4, we use max{(β̂(i) − β̂(i−1))2, (γ̂(i) − γ̂(i−1))2} < .001 or i > 100.
The coefficient estimates are the average of the estimates from the m imputations,
and the variance estimates are the weighted average of the within imputation vari-
ances and between imputation variance. The second term of the variance components
in equations 2.11 and 2.12 has an additional weight 1/m which is an inflation factor
used to take account of a finite number of imputations (Rubin [17]; Tanner and Wong
[22]; Schenker and Welsh [18]). As the size of the multiple imputation m does not
necessarily to be large, we choose m = 10 in our study as suggested by Pan [12].









As suggested by Taylor [23], we apply zero constraint to the survival function.
That is, the survival probability for uncured patient after the maximum value of
finite Rj will be restricted to zero. When we update w, we calculate the survival
probability at the left time points for right censored patients, based on the estimated
step function of baseline survival from previous iteration.
In (s2b) of PMDA (or (s3b) of ANDA), we sample T (i+1)(k),j from Ŝ
(i)
u(k),j condition-
al on (Lj, Rj] for non-right-censored patients. That is, for the jth patient with
Rj < ∞, we have {t1, t2, ..., tnj} discrete time points in interval (Lj, Rj]. The cor-





u(k),j(tns). Thus we sample T
(i+1)
(k),j from {t1, t2, ..., tnj} with probabil-
ity proportional to {p1, p2, ..., pnj}.
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Pan [12] mentioned that the results from PMDA is asymptotically equivalent to
that based on ANDA, except that PMDA will underestimate the variance when the
data has relatively large proportion of right censoring observations. Because we usu-
ally have high proportion of censoring when there exists cure rate, we expect that
the performance of the algorithm based on ANDA will be over PMDA in variance
estimation. We compare these two approaches in the simulation study using different





3.1 Performance of PMDA and ANDA
We design a simulation study to examine the performance of the proposed method.
In our design, we have two predictors in the latency part, x1 follows uniform distribu-
tion U(0, 2) and x2 follows bernoulli distribution Ber(.5). For the incidence part, we
have z1 follows U(0, 2) and z2 follows Ber(.5). The coefficients are set to β = (1,−1)
and γ = (0, 1,−1), yielding an average cure probability of 40% and γ = (−1, 1,−1)
yielding an average cure probability of 60%. For the baseline distribution, we use a
Weibull baseline distribution with shape parameter 2 and scale parameter 1 and a
Lognormal baseline distribution with log mean of 0 and log standard deviation of 0.2.
A sample size of 500 is used.
We generate the interval censored survival time in the following way: each subject
has p equally spaced random intervals of length τ that their events could fall into,
defined as the time points 0 < Yj < Yj +τ < ... < Yj +p×τ <∞ where Yj ∼ U(0, ν),
j = 1, 2, . . . , n. We have left censoring if the generated survival time Tj < Yj and the
patient is not cured uj = 1. We have right censoring if Tj > Yj + p× τ or the subject
is cured uj = 0. Otherwise, if the patient is not cured uj = 1, and Tj ∈ (Yj, Yj+p×τ ],
we have interval censoring and we choose the smallest interval which covers the true
event time. We fix ν = 1 and τ = 0.2, and adjust p to have different right censoring
rate such as 45% or 60% for 40% cure rate.
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Table 3.1 Simulation Results for 1000 Replications for 40% Cure Rate
Fully Parametric MI PMDA MI ANDA
cens% par. Bias StDev StErr CP Bias StDev StErr CP Bias StDev StErr CP
Lognormal Baseline
45 γ0 -0.008 0.218 0.226 0.956 0.011 0.225 0.227 0.948 -0.002 0.223 0.229 0.960
γ1 0.007 0.191 0.191 0.952 0.021 0.197 0.192 0.953 0.010 0.193 0.193 0.952
γ2 0.000 0.205 0.214 0.963 -0.015 0.212 0.215 0.961 -0.005 0.210 0.216 0.956
β1 0.021 0.126 0.136 0.973 0.032 0.132 0.132 0.945 0.015 0.134 0.143 0.964
β1 -0.024 0.148 0.150 0.959 -0.043 0.156 0.149 0.941 -0.026 0.157 0.155 0.949
60 γ0 0.004 0.272 0.285 0.965 0.036 0.289 0.261 0.931 0.033 0.288 0.300 0.954
γ1 0.024 0.244 0.242 0.950 0.050 0.260 0.222 0.904 0.037 0.259 0.254 0.938
γ2 -0.020 0.271 0.271 0.948 -0.045 0.286 0.248 0.909 -0.032 0.285 0.284 0.941
β1 0.018 0.171 0.169 0.944 0.032 0.180 0.160 0.910 0.004 0.180 0.180 0.942
β1 -0.002 0.176 0.186 0.960 -0.022 0.186 0.180 0.941 0.008 0.184 0.188 0.954
Weibull Baseline
45 γ0 0.006 0.240 0.228 0.938 0.013 0.247 0.226 0.926 -0.006 0.244 0.227 0.933
γ1 0.000 0.200 0.192 0.940 0.004 0.208 0.191 0.935 -0.013 0.203 0.191 0.938
γ1 -0.006 0.220 0.216 0.940 -0.011 0.227 0.214 0.935 0.006 0.222 0.214 0.941
β1 0.026 0.132 0.136 0.952 0.022 0.139 0.130 0.924 -0.006 0.140 0.138 0.949
β1 -0.028 0.148 0.151 0.950 -0.028 0.152 0.146 0.936 -0.006 0.154 0.151 0.942
60 γ0 -0.012 0.295 0.309 0.957 -0.014 0.320 0.262 0.890 -0.037 0.313 0.310 0.939
γ2 0.031 0.265 0.265 0.957 0.038 0.293 0.224 0.879 0.001 0.265 0.262 0.944
γ2 -0.012 0.274 0.293 0.964 -0.017 0.310 0.251 0.895 0.014 0.283 0.292 0.945
β1 0.015 0.173 0.175 0.954 0.008 0.183 0.159 0.910 -0.020 0.183 0.190 0.949
β1 -0.009 0.196 0.197 0.953 -0.009 0.205 0.179 0.897 0.036 0.203 0.195 0.940
We did 1000 replications for each simulation setting, and report the bias, average
estimated standard deviation (StErr), empirical standard deviation (StDev) and em-
pirical coverage probability (CP). Our multiple imputation algorithms based on both
ANDA and PMDA are reported, and all the results are compared with the fully para-
metric maximum likelihood estimates. Table 3.1 is for the 40% cure rate probability
and Table 3.2 is for the 60% case. Basically, all the three approaches are comparable
with respect to biases under the Weibull and Lognormal baseline distributions. The
StErr and StDev for our proposed algorithm based on ANDA are similar and the
coverage probabilities are close to 95%, the overall performance of this approach is
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Table 3.2 Simulation Results for 1000 Replications for 60% Cure Rate
Fully Parametric MI PMDA MI ANDA
cens% par. Bias StDev StErr CP Bias StDev StErr CP Bias StDev StErr CP
Lognormal Baseline
65 γ0 -0.005 0.240 0.249 0.955 0.017 0.247 0.246 0.947 0.007 0.246 0.254 0.957
γ1 0.022 0.197 0.201 0.950 0.037 0.202 0.200 0.939 0.030 0.200 0.205 0.947
γ2 -0.023 0.227 0.225 0.950 -0.036 0.233 0.224 0.939 -0.029 0.234 0.230 0.948
β1 0.019 0.185 0.189 0.954 0.045 0.197 0.180 0.929 0.015 0.198 0.202 0.951
β2 0.001 0.202 0.207 0.957 -0.031 0.214 0.201 0.934 -0.007 0.211 0.214 0.962
80 γ0 -0.011 0.364 0.354 0.950 0.066 0.402 0.286 0.822 0.068 0.399 0.386 0.929
γ1 0.028 0.296 0.286 0.942 0.090 0.331 0.235 0.822 0.069 0.328 0.315 0.939
γ2 -0.018 0.311 0.318 0.952 -0.077 0.352 0.261 0.859 -0.052 0.341 0.349 0.935
β1 0.036 0.266 0.273 0.958 0.007 0.276 0.242 0.916 -0.077 0.262 0.270 0.941
β2 -0.025 0.310 0.304 0.942 -0.009 0.322 0.273 0.894 0.086 0.307 0.289 0.917
Weibull Baseline
65 γ0 -0.008 0.250 0.252 0.949 0.002 0.256 0.245 0.931 -0.016 0.257 0.253 0.950
γ1 0.026 0.204 0.202 0.946 0.035 0.211 0.198 0.936 0.023 0.206 0.203 0.952
γ2 -0.025 0.232 0.226 0.938 -0.033 0.237 0.222 0.932 -0.021 0.234 0.228 0.936
β1 0.016 0.185 0.193 0.953 0.014 0.198 0.177 0.917 -0.036 0.196 0.198 0.940
β2 -0.007 0.215 0.217 0.948 -0.009 0.223 0.198 0.923 0.034 0.216 0.213 0.946
80 γ0 0.000 0.361 0.380 0.975 0.019 0.399 0.286 0.857 -0.046 0.376 0.361 0.929
γ1 0.049 0.346 0.339 0.951 0.083 0.366 0.235 0.842 -0.001 0.292 0.289 0.945
γ2 -0.042 0.341 0.349 0.964 -0.070 0.388 0.261 0.858 0.001 0.323 0.320 0.935
β1 0.057 0.280 0.277 0.939 0.040 0.297 0.234 0.871 -0.012 0.276 0.305 0.957
β2 -0.052 0.306 0.310 0.953 -0.033 0.313 0.262 0.908 0.050 0.304 0.305 0.934
similar to the fully parametric method. The StErr and StDev for PMDA are similar
when the censoring rate is small, for example 45% right censoring under 40% cure
rate and 65% right censoring under 60% cure rate. However, PMDA underestimates
variance when censoring rate is large, which results in a low coverage probability.
We further investigate the multiple imputation methods with regard to their esti-
mated survival curves. Curves under both multiple imputation methods are similar in
different settings. For illustration purpose, we present the estimated baseline survival
curves along with 2.5% and 97.5% quartiles under the lognormal and weibull settings
with 40% cure rate in Figures 3.1 to 3.4. These were obtained from the multiple
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Figure 3.1 Estimated Baseline Survival Probability for Lognormal with 45% Censoring
























Figure 3.2 Estimated Baseline Survival Probability for Lognormal with 60% Censoring
imputation approach with ANDA where the solid lines are the truth. Plots for the
60% cure rate are very similar to these results. It turns out that the estimated curves
are close to the truth for most of the time points, and the small differences at the tail
of the survival functions for large censoring cases may due to the zero-tail restriction.
The true survival curves lie in the 95% confidence interval, which demonstrates the
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Figure 3.3 Estimated Baseline Survival Probability for Weibull with 45% Censoring
























Figure 3.4 Estimated Baseline Survival Probability for Weibull with 60% Censoring
validity of the proposed method.
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3.2 Sensitivity Analysis: link functions for uncured rate
Furthermore, we conducted a sensitivity analysis for our proposed algorithm based
on ANDA with respect to different link functions, such as logit link, probit link and
complimentary log-log link, for the cure probability. Similar to the setting in the
simulation study, we have two predictors in the latency part, x1 follows uniform dis-
tribution U(0, 2) and x2 follows bernoulli distribution Ber(.5). For the incidence
part, we have z1 follows Ber(.5) and z2 follows U(0, 2). The coefficients are set to
β = (1,−1) and γ = (0, 1,−1). Weibull baseline distribution with shape parameter
2 and scale parameter 1 is used and the sample size is set to 500.
For the purpose of easy interpretation of cure probability, we fix z2 at the global
mean value of 1, and calculate the uncure rate for z1 = 0 and z1 = 1 separately. The
true values for the uncure rate π(z1 = 0) and π(z1 = 1) and right censoring rate are
listed in Table 3.3 for each link function.
Table 3.3 Setting: Cure Rate and Right Censoring Rate
Link π(z1 = 0) π(z1 = 1) Right Cen.%
Logit 0.269 0.500 0.682
Probit 0.308 0.632 0.728
Cloglog 0.159 0.500 0.582
We generate data with one of the link functions, for example logit link, and fit
the data using all the three links separately. We calculate the uncure rate π(z1 = 0)
and π(z1 = 1), as well as their variance estimates based on delta method. The bias,
average estimated standard deviation (StErr), empirical standard deviation (StDev)
and empirical coverage probability (CP) for uncure rates and coefficients for the
latency part are reported in Table 3.4. From the results, we find the proposed multiple
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imputation approaches are pretty stable in estimating the uncure rate when we specify
a different link function for the model regarding to biases. Variances for the latency
part are close to 95%.
Table 3.4 Sensitivity Analysis for Different Link Functions
Logit Probit Cloglog
par. Bias StDev StErr CP Bias StDev StErr CP Bias StDev StErr CP
Logit
π(z1 = 0) 0.000 0.034 0.034 0.946 0.001 0.033 0.033 0.950 -0.001 0.032 0.032 0.948
π(z1 = 1) -0.002 0.042 0.041 0.938 -0.005 0.042 0.040 0.934 -0.014 0.041 0.040 0.918
β1 -0.021 0.203 0.200 0.920 -0.028 0.206 0.199 0.924 -0.021 0.202 0.200 0.938
β2 0.035 0.232 0.215 0.938 0.038 0.235 0.215 0.914 0.038 0.235 0.215 0.918
Probit
π(z1 = 0) -0.003 0.028 0.027 0.922 -0.002 0.029 0.028 0.918 -0.003 0.035 0.034 0.934
π(z1 = 1) 0.000 0.048 0.044 0.928 -0.005 0.043 0.041 0.936 -0.007 0.043 0.041 0.936
β1 -0.034 0.212 0.211 0.946 -0.039 0.216 0.209 0.936 -0.026 0.166 0.173 0.942
β2 0.022 0.255 0.225 0.916 0.031 0.254 0.227 0.914 0.024 0.194 0.187 0.936
Cloglog
π(z1 = 0) 0.000 0.038 0.036 0.942 0.004 0.037 0.035 0.932 -0.003 0.035 0.034 0.934
π(z1 = 1) 0.008 0.041 0.041 0.934 0.003 0.041 0.039 0.934 -0.007 0.043 0.041 0.936
β1 -0.030 0.167 0.173 0.948 -0.032 0.168 0.174 0.950 -0.026 0.166 0.173 0.942
β2 0.025 0.195 0.188 0.934 0.028 0.197 0.188 0.928 0.024 0.194 0.187 0.936
3.3 Sensitivity Analysis: interval and rounded right censoring
Since day is a confidential variable to some U.S. registries, only the processed
survival month is available for analysis in the SEER data [21]. The definition of
survival months after diagnosis (T ) is
T = floor
( last contact date− diagnosis date
average days in amonth
)
,
where floor(·) denotes a function rounding down to the integer. Therefore, even for
the complete observations, the exact survival month cannot be read directly from
the SEER data. The survival month after diagnosis T indicates that the exact event
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time happens in the interval [T, T + 1), which can be viewed as an interval censored
survival data.
Here, we perform a simulation study to mimic the rounding down procedure and
compare the continuous approach for right censored data and our proposed method
for interval censored data. Covariates and coefficients for the cure rate part and the
latency part are set to be the same as that in Section 3.1, baseline distribution for
survival time X is Weibull with shape parameter 1 and scale parameter 200. Based on
these, the cure rate is about 60% and the mean survival time is around 430. Censoring
time C follows Uniform distribution from 0 to 2000, leading to an average right cen-
soring rate of 68%. Sample size of 500 is used. We denote this data set as the Original
Dataset D = {T, δ,x, z}, where T = min(X,C) and δ = 1(X≤C). We divide T by a
unit l and round down to the integer like Equation 3.3, that is, let T (1) = floor(T/l),
we have the data set with rounded down survival times D(1) = {T (1), δ,x, z}. As we
claimed that the interval censoring data set is D(2) = {L,R,x, z}, where L = T (1)
and R = T (1) + 1 if δ = 1, otherwise R =∞.
The unit is chosen to be weekly (l = 7), monthly (l = 30) and quarterly (l = 90).
Right censored data sets D and D(1) are fitted using the “smcure" package in R,
and the interval censored data D(2) is fitted using our proposed algorithm based on
ANDA. Biases and Coverage probabilities (CP) are reported. The estimated baseline
survival curves are compared with the true distribution from Figure 3.5 to 3.7.
Based on the results, the “smcure" function for the rounded down right censoring
data set D(1) is sensitive to the unit l. As the unit l increases, biases of the two β
coefficients in the latency part increases, and coverage probabilities decreases. But if
we treat the data set as interval censored likeD(2), and fit with our proposed method,
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Table 3.5 Estimates for Rounded Down Survival Times
smcure for D smcure for D(1) ANDA for D(2)
par. Bias CP Bias CP Bias CP
l = 7
γ0 -0.038 0.940 -0.036 0.935 -0.029 0.940
γ1 -0.030 0.890 -0.029 0.905 -0.028 0.905
γ2 0.004 0.950 0.003 0.940 0.002 0.950
β1 -0.060 0.965 -0.076 0.950 -0.072 0.935
β2 0.031 0.955 0.046 0.950 0.033 0.960
l = 30
γ0 -0.029 0.945 -0.019 0.935 -0.012 0.970
γ1 -0.032 0.950 -0.027 0.960 -0.028 0.960
γ2 0.017 0.970 0.013 0.955 0.013 0.955
β1 -0.036 0.950 -0.101 0.910 -0.050 0.925
β2 0.045 0.950 0.112 0.890 0.049 0.950
l = 90
γ0 -0.018 0.930 0.040 0.925 0.034 0.945
γ1 0.005 0.945 0.028 0.930 0.019 0.940
γ2 -0.010 0.930 -0.034 0.935 -0.021 0.925
β1 -0.031 0.950 -0.227 0.740 -0.056 0.935
β2 0.017 0.975 0.221 0.685 0.045 0.940
we have smaller biases and the coverage probabilities are close to 95%. We also com-
pared the estimated baseline curves from these three approaches, the red line is the
true distribution, the black line is from “smcure" for D, the blue line is from ANDA
for D(2). Both of these two step functions are close to the truth under all settings.
However, the estimated baseline curves for rounded down right censored times (green
lines) get far away from the truth as the unit l goes up.
Therefore, we can increase the accuracy of estimates by treating the rounded down
right censored data as interval censored data in the mixture cure model. And the
method will be applied in the SEER Breast Cancer data in Chapter 4.
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Figure 3.5 Estimated Baseline Survival Probability for Sensitivity Analysis (Weekly)
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Figure 3.6 Estimated Baseline Survival Probability for Sensitivity Analysis (Monthly)
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Breast cancer is the most common cancer in women worldwide, and approxi-
mately 12.3 percent of women will be diagnosed with breast cancer at some point
during their lifetime, based on 2008-2010 Surveillance, Epidemiology, and End Re-
sults (SEER) data [20].
Cancer stage at diagnosis, which characterizes the extent of cancer in the body,
determines treatment options and has a strong influence on the length of survival. It
has five main categories for cancer cases. In situ refers to the case where abnormal
cells are present only in the layer of cells in which they developed. Localized means
the cancer is limited to the organ in which it began, without evidence of spread. In
the regional case, cancer has spread beyond the primary site to nearby lymph nodes
or tissues and organs. For distant stage, cancer has spread from the primary site
to distant tissues or organs or to distant lymph nodes. And if There is not enough
information to determine the stage, the cancer is unstaged. For example, in breast
cancer cases, the 5-year survival probability for localized breast cancer is as high as
98.5%.
4.1 Dataset Description
For the purpose of illustration, we extracted 2000-2010 Greater Georgia breast
cancer dataset from the SEER cancer incidence public-use database [21]. We choose
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Greater Georgia because we want to adjust the effect of race on survival probabilities,
and we have relatively high proportion for African Americans in this state, approxi-
mately 17.6% of the population.
Variables of interest include: age at diagnosis, marital status (single, married or
other), SEER summary stage (in situ, local, reginal or distant), race (white, black
or other) and survival months after diagnosis. Observations with missing values for
any of these variables are excluded from this study. Among these variables, the main
covariate of interest is the stages of cancer.
Since there are only 54 subjects with other race category, we also exclude these
observations. Subjects with recurrent events are not under our consideration and
were excluded as well. Subjects who lost to follow-up after diagnosis or with incom-
plete or unknown survival time were also deleted.
As a result, we have a total of 7,249 patients; 394 of them have tumor in situ,
4,182 of them have local cancer stage, 2,458 of them have reginal cancer stage and
215 have distant cancer stage. We have 86.3% of the observations that are subject to
right censoring, such a high right censoring proportion suggests that a proportion of
these patients may be cured.
4.2 Preliminary Data Analysis
As we mentioned in 3.3, the survival month T was calculated based on the last
contact date and the diagnosis date, and rounded down to the integer. Thus we mod-
ify the derived follow-up survival month T into time intervals. For example, the true
survival time for subject j is within [Tj, Tj + 1) months, where Tj was the derived
survival month in the dataset. We draw the Turnbull [24] NPMLE fitted survival
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curves with respect to the four breast cancer stages (Fig. 4.1). The curves show that
the survival rate decreases when the stage becomes severe. Furthermore, there is a
leveling off of survival curves at the end of study, which indicates a possible cure rate
in breast cancer. As we claimed before, by treating the data as interval censored, we
































Figure 4.1 Turnbull NPMLE for Different Cancer Stages
can increase the accuracy of the estimates in the mixture cure model. Therefore, we
model the interval censored survival times with the stage variable using the proposed
multiple imputation algorithm based on ANDA, and the results are listed in Table
4.1. Cure rate and survival probability of uncured patients are compared among the
four cancer stages: in situ, local, regional and distant. Survival probabilities for the
four stages are calculated and compared with the results from Turnbull [24] NPMLE
in figure 4.2. From the plot, we can see that our results are pretty close to the curves
based on the NPMLE.
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Table 4.1 Crude Model for SEER Breast Cancer Study
Crude Model
Parameters Est Std P
Incidence part
Intercept -3.169 0.347 <.001
Stage : Local 0.798 0.353 0.024
Stage : Regional 2.199 0.349 <.001
Stage : Distant 5.366 0.542 <.001
Latency part
Stage : Local 0.945 0.535 0.077
Stage : Regional 1.150 0.525 0.029
Stage : Distant 1.762 0.470 <.001
The stage in situ is treated as baselines in the model. Based on the results, we
can derive cure probabilities for different stages and hazard ratios between two of the
stages for uncured patients. For example, the cure rate for in situ, local, regional
and distant stages are 96.0%, 91.5%, 72.5% and 10.0% respectively, and the hazard
ratio between regional stage and stage in situ for uncured patients is 3.16 with 95%
confidence interval (1.128, 8.837). Therefore, as the cancer progresses from stage
in situ to distant, cure probabilities decreases and hazard risk for uncured patients
increases.
4.3 Adjusted Model
We apply our multiple imputation method based on ANDA to the breast cancer
dataset described above. Cure rate and survival probability of uncured patients are
compared among the four cancer stages after adjusted for age at diagnosis, race and
marital status at diagnosis.
We use m = 10 imputations in our MI-ANDA algorithm. The estimated coeffi-
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Figure 4.2 Estimated Survival Curves in Crude Model(dotted line for Turnbull and
solid line for MI-ANDA)
cients and standard deviations are listed in Table 4.2. The stage in situ, other marital
status and race of black were treated as baselines in the model. Based on the results,
we can derive cure probabilities for different stages and hazard ratios between two of
the stages for uncured patients adjusting for the other covariates. For example, the
cure rate for in situ, local, regional and distant stages are 95.5%, 89.9%, 69.1% and
8.5% respectively, and the hazard ratio between regional stage and stage in situ for
uncured patients is 3.09 with 95% confidence interval (0.970, 9.839).
We also have some interesting findings for these predictor variables. In the ad-
justed model, as the cancer progresses from stage in situ to distant, cure probabilities
decreases and hazard risk for uncured patients increases. Cure rate is not significantly
different for people at different age but the survival probability of uncured patients
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Table 4.2 Adjusted Model for SEER Breast Cancer Study
Adjusted Model
Parameters Est Std P
Incidence part
Intercept -3.050 0.438 <.001
Stage : Local 0.866 0.459 0.059
Stage : Regional 2.245 0.466 <.001
Stage : Distant 5.426 0.640 <.001
Age 0.003 0.003 0.391
Marital : Single 0.238 0.139 0.086
Marital : Married -0.284 0.108 0.008
Race : White -0.388 0.094 <.001
Latency part
Stage : Local 0.914 0.584 0.117
Stage : Regional 1.128 0.591 0.056
Stage : Distant 1.606 0.580 0.006
Age 0.007 0.003 0.013
Marital : Single 0.035 0.134 0.795
Marital : Married -0.066 0.099 0.504
Race : White -0.146 0.089 0.100
is actually affected by age. Women with different marital status have significantly
different cure rate, but survival probabilities for uncured patients are similar. White
women have significantly higher cure rate compared with black women, however, for
uncured patients, the difference between survival probabilities for different races are
not significant.
Predicted survival curves for the three stages in the adjusted model are in Figure
4.3, where age, marital status and race are fixed at median values. Based on the
estimated overall survival curves, we can conclude that the local stage have a highest
survival probability, while the distant stage actually have the lowest survival proba-
bility, and the regional stage is in between them.
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In our paper, we developed a multiple imputation algorithm for interval censored
data under the proportional hazards mixture cure model. Our algorithm is based on
the Asymptotic normal data augmentation (ANDA) or the Poor Man’s data augmen-
tation (PMDA). Based on the simulation results, we find these two approaches are
close to each other when we have relatively small right censoring rate for uncured
patients. However, when we have large proportion of right censoring that could not
be explained by the incidence part, the algorithm based on PMDA will underestimate
the variance.
From the sensitivity analysis for link functions in the cure rate part, we find the
estimates for uncure rate and coefficients in latency part are quite stable. Therefore,
we do not need to worry about which link function to choose for the incidence part
when we apply the model to our data in practice. We also proved in another sensitiv-
ity analysis that by treating the rounded right censored survival months as interval
censored data, and fit with the proposed method, we can increase the accuracy of
estimates in the model.
The method was further applied to the 2000-2010 Greater Georgia SEER Breast
cancer study to compare different cancer stages under the mixture cure model. The
results are easily interpreted based on the cure probability for different cancer stages
and hazard ratio in different stages.
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One of the greatest advantages of this method is the easy application in soft-
wares. We can use some well established softwares such as R and SAS to implement
the algorithm. In R, the “glm" function can be used for the incidence part and the
“coxph" function in the “survival" package can be used for the latency part. In SAS,
the “GLM" and “PHREG" procedures can be used. Since these existing softwares are
efficient in calculating both of the estimates and the variance needed in the algorithm,
and the imputation number m usually is small, our proposed algorithm is relatively
fast to obtain the estimates.
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L<-t.true<t.obs & ui==1 # left censor indicator
M<-!(t.true<t.obs | t.true>t.obs+nk*len) & ui==1












































































# M-step2: Cox PH model
sdata<-subset(data,data$y==1)
sxx<-subset(xx,data$y==1)
























estgam<-apply(na.omit(temp.gam),2,mean) # Estimated gamma coef.
























mf <- match.call(expand.dots = FALSE)
temp <- c("", "formula", "data", "copy.data", "na.action")
mf <- mf[match(temp, names(mf), nomatch = 0)]
mf[[1]] <- as.name("model.frame")
temp.x<-terms(formula, data = copy.data)
temp.z<-terms(curefun, data = copy.data)
mf$formula <- temp.x
mf <- eval(mf, parent.frame())
Y <- model.extract(mf, "response")
attr(temp.x, "intercept") <- 0




































































beta0<-c(1,-1) #parameters for cox model








temp.em1<-MI_ANDA(formula = Surv(left,right,type="interval2")~ x1+x2,
curefun= status~ z1, data =sdata, linkfun="logit",max.iter=100,
cov.rate=1e-3,m=m),silent=TRUE)
}
50
